At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
In Brief
A Phase 3 clinical trial evaluating three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and 3 other interventions for Prostate Cancer. Active but no longer recruiting, targeting 2,590 participants across 478 sites in 6 countries.
Detailed Summary
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.
Study Details
Timeline
Interventions
Daily fractions
Daily fractions
Implant
Tablet
Injection